|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
This study was to investigate the features of renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions (Xp11.2-RCC) on conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS).
|
29333109 |
2017 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation.
|
27450657 |
2016 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Immunohistochemistry and molecular analyses led to the reclassification of 3 tumors as ccRCC and TFE3 translocation carcinomas.
|
25970683 |
2015 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: findings on MRI and computed tomography imaging.
|
24136829 |
2014 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
However, the expression of cathepsin K in specific genetic subtypes of Xp11 translocation carcinomas, as well as alveolar soft part sarcoma, which harbors the same ASPSCR1-TFE3 gene fusion as some Xp11 translocation carcinomas, has not been addressed.
|
21602817 |
2011 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Carcinomas associated with somatic translocations of TFE3 and TFEB comprise a significant proportion of pediatric renal carcinomas.
|
19494850 |
2009 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Renal carcinomas harboring the TFE-3 translocation are rare and occur predominately in children and adolescents.
|
18358634 |
2008 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Twenty-nine cases were diagnosed as TFE3 and 2 as TFEB renal translocation carcinomas, including 13 males and 18 females, mean age 24.6 years.
|
18344867 |
2008 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
These include the Xp11-translocation carcinomas, which bear TFE3 gene fusions, and the renal carcinomas with the t(6;11)(p21;q12), which bear an Alpha-TFEB gene fusion.
|
15848741 |
2005 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults.
|
15316311 |
2004 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Thirty-nine of 40 neoplasms characterized by TFE3 gene fusions (19 of 19 alveolar soft part sarcoma, 20 of 21 renal carcinomas) demonstrated moderate or strong nuclear TFE3 immunoreactivity.
|
12766578 |
2003 |
|
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We report the morphologic, immunophenotypic, ultrastructural, and molecular features of 11 renal carcinomas bearing a t(X;1)(p11.2;q21) and/or the resulting PRCC-TFE3 gene fusion.The male/female ratio was 4:7.
|
12459622 |
2002 |